Amy Feng - Concepedia

Author

Amy Feng

Amgen (United States)

Also Known As

AMY FENG, Amy Feng, Amy J Feng, Amy Shi Nan Feng, Methner

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)The University of Texas MD Anderson Cancer Center University of Minnesota University of California, Los Angeles Stanford University

About

Amy Feng is an author at Amgen (United States) specializing in medicine, cancer therapeutics, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	447
2	Health Sciences	2	2	124
3	Biomedical Engineering	1	1	66
4	Emergency Medicine	1	1	23
5	Immunology	1	1	14

Amy Feng

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Surgical Downstaging in an Open-Label Phase II Trial of Denosumab in Patients with Giant Cell Tumor of Bone Piotr Rutkowski, Stefano Ferrari, R. J. Grimer, Annals of Surgical Oncology	2015	182
Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors David H. Henry, Saroj Vadhan‐Raj, Vera Hirsh, Supportive Care in Cancer Bone DiseaseAdvanced CancerBone HealthMedicineCancer Management	2013	182
Reactive Oxygen Species from Human Astrocytes Induced Functional Impairment and Oxidative Damage Wen S. Sheng, Shuxian Hu, Amy Feng, Neurochemical Research InflammationHealth SciencesMedicineLipid PeroxidationPhysiology	2013	110
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis Mark Lebwohl, Leon Kircik, Angela Moore, JAMA	2022	104
“A Baby Was an Added Burden”: Predictors and Consequences of Unintended Pregnancies for Female Sex Workers in Mombasa, Kenya: A Mixed-Methods Study Stanley Lüchters, Wilkister Bosire, Amy Feng, PLoS ONE	2016	78
Effects of denosumab on pain and analgesic use in giant cell tumor of bone: Interim results from a phase II study Javier Martín‐Broto, Charles S. Cleeland, Paul Glare, Acta Oncologica	2014	69
Anti–Factor Xa and Activated Partial Thromboplastin Time Measurements for Heparin Monitoring in Mechanical Circulatory Support Sirtaz Adatya, Nir Uriel, Hirad Yarmohammadi, JACC Heart Failure ThrombosisCardiovascular DiseaseBlood PlateletHeparin MonitoringHematology	2015	66
Darbepoetin Alfa Impact on Health Status in Diabetes Patients with Kidney Disease Eldrin F. Lewis, Marc A. Pfeffer, Amy Feng, Clinical Journal of the American Society of Nephrology	2011	65
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone Jacob Engellau, Leanne L. Seeger, R. J. Grimer, World Journal of Surgical Oncology	2018	53
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease Ingo Diel, Jean‐Jacques Body, Alison Stopeck, European Journal of Cancer MedicineMetronomic TherapyPathologyMetastatic Bone DiseaseCancer Patients	2015	52

Page 1